Ledning
MANAGEMENT
Peter Åsberg
CEO, Ph.D. Bioch. Eng.
Born 1973
Education Ph.D. Applied Biochemistry and Physics; M.Sc. Biotechnology, Linköping University, diploma work at Stanford University
Experience 20+ years of experience in senior management roles within the pharmaceutical and biotech industry. Previously at BioChromix Pharma, Cadila Pharmaceuticals Sweden, Aegate Ltd and Olink Bioscience.
Shares 1250 shares, and 6100 KPO 2023/2028:1, per 31 December 2025
Malin Vågerö
Director of R&D, B.Sc. Chem.
Born 1969
Education B.Sc. Chem., Stockholm University
Experience 25+ years in pharmaceutical development in large and small companies, from early phase to commercial launch and product maintenance. Previous management roles at AstraZeneca, Nanologica and APL.
Shares 650 TO 2023/2028:3, per 31 December 2025
Martina Ferneman
Commercial Director, MBA
Born 1967
Education M.Sc. Chemical and Administrative Sciences, Karlstad University; MBA, Stockholm University
Experience 25+ years in the life science industry, sales, marketing and business development. Previous roles at Biacore, Affibody, and global CDMOs Recipharm and NorthX Biologics.
Shares No shares per 31 December 2025
Sofia Mogensen
Project Manager, M.Sc. Chem. Eng.
Born 1971
Education M.Sc. Chem. Eng., Uppsala University; B.Sc. Behavioural Science, Stockholm University
Experience 20+ years as project leader in the life science industry, CMC, Product Transfers, GMP, Manufacturing. Previous roles at Xbrane Biopharma, Fresenius Kabi, Mercodia and Orexo.
Shares 1250 shares held via a corporate entity, per 31 December 2025
Stefan Ström
CFO, B.Sc. Economics
Born 1958
Education B.Sc. Economics, Lund University
Experience Long experience as CFO for public companies. Previously at I.A.R. Systems Group AB (publ), listed on Nasdaq Stockholm Mid Cap.
Shares 833 shares, and 550 TO 2023/2028:3, per 31 December 2025
Marc Willuhn
Process Development Director, Ph.D
Born 1973
Education Ph.D. Organic Chemistry, Ruhr-Universität Bochum/Max-Planck-Institut für Kohlenforschung; M.Sc. Chem, Gerhard-Mercator-Universität Duisburg.
Experience 20+ years in the pharma industry. Leading global roles in pharmaceutical development at Baxter Healthcare and Fresenius Kabi.
Shares No shares per 31 December 2025